TB disruptions endanger millions

On World Tuberculosis Day (24 March), WHO urges urgent investment to sustain TB care and support worldwide.

One year of historic malaria vaccine rollout in Africa

The vaccines have proven effective. Clinical studies show that the RTS,S/AS01 malaria vaccines prevent over half of malaria cases in children during the first year.

One man’s dream of a hepatitis-free Tanzania 

An estimated 254 million people globally are living with chronic hepatitis B infection, and roughly 1.1 million people die each year from the infection.

WHO Prequalifies first maternal RSV Vaccine

The respiratory syncytial virus (RSV) causes more than 3.6 million hospitalizations and about 100 000 deaths in children under 5 years of age.

Needle-free polio vaccine boosts coverage in Nigeria

Needle-free, intradermal delivery of the inactivated polio vaccine has the potential to improve vaccination coverage and reduce costs in routine immunization programs.

Europe sees worst measles surge in 25+ years

"Measles is back, and it’s a wake-up call. Without high vaccination rates, there is no health security", says Dr Hans Henri P. Kluge, WHO Regional Director for Europe.

Africa free of meningitis A outbreaks since 2017

This milestone is largely credited to the introduction of the meningitis A conjugate vaccine, which was incorporated into routine immunization schedules.

Under the banner, ‘Immunization for All is Humanly Possible’, World Immunization Week 2025 (24-30 April) aims to ensure even more children, adolescents, adults – and their communities – are protected against vaccine-preventable diseases.  

• Digital adaptation kit for immunizations: operational requirements for implementing WHO recommendations in digital systems 
  (part of SMART guidelines)
• Targeted and selective strategies in measles and rubella vaccination campaigns: Interim guidance 

• WHO EpiBrief: Data and analysis on measles and rubella (Jan. to June 2024), diphtheria and pertussis (2023). 

• Annual Meeting on Meningitis-MenAfriNet, Maternal and Neonatal Tetanus (MNT), Yellow Fever, Diphtheria, Typhoid and Measles and Rubella in Africa.

• Call for contributions and save the date for the Immunization Economics IHEA 2025 Pre-Congress 

Contribute to the next issue of the GIN

The next update will be in January 2025. To contribute, please click on this link to submit an article by April 21st. 
If you have any questions or feedback, please contact: globalimmunnews@who.int